Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 13 of 13

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract September 2016

Progressive experimental choroidal neovascularization of both New Zealand White and Dutch belt rabbit after sustained release of both VEGF and bFGF within the subchoroidal space

Corinne G Wong; Fred N. Ross-Cisneros; Thomas C Bruice; Grit Zahn; Tim You

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12)

ARVO Annual Meeting Abstract June 2015

Simultaneous sustained release of VEGF and bFGF from a non-biodegradable implant in the supra-choroidal space induces experimental choroidal neovascularization in both New Zealand white and Dutch belt rabbits.

Corinne G Wong; Lucy H Young; Kathy Osann; Ricardo AP Carvalho; Timothy You; TC Bruice

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):372.

ARVO Annual Meeting Abstract April 2014

Anti-Ras Molecule Inactivates Experimental Retinal Neovascularization After Intravitreal Non-Biodegradable VEGF/bFGF Implant in the Rabbit Model

Corinne G Wong; Kathryn Osann; Hung Tao Hsu

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1965.

ARVO Annual Meeting Abstract March 2012

Utility Of Dual Electrochemical Gsh And Gssh Evaluation And Other Redox/detoxification Quantitation As Functional Parameters In Assessment Of Retinal Toxicity During In Vivo Drug Studies With Large Animal Eyes

Corinne G. Wong; Thomas C. Bruice

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5557.

ARVO Annual Meeting Abstract April 2011

Experimental CNV in Cynomolgus Monkeys after Sustained Release of VEGF and bFGF within the Suprachoroidal Space: Part 2. Natural History

Corinne G. Wong; Ton Lin; Yong Li; James Burke; Timothy You; Larry Wheeler; Corine Ghosn

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4000.

ARVO Annual Meeting Abstract April 2010

Experimental CNV in Cynomolgus Monkeys After Sustained Release of VEGF and bFGF Within the Suprachoroidal Space: A Proof of Concept Study

C. G. Wong; Y. Li; T. Lin; J. Burke; L. Wheeler; C. Ghosn

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):3359.

ARVO Annual Meeting Abstract April 2009

Natural History of Progressive Experimental CNV in the Rabbit After Sustained Release of Both VEGF and bFGF Within the Supra-Choroidal Space

C. G. Wong; T. You; R. Carvalho

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2970.

ARVO Annual Meeting Abstract April 2009

Pentacam Topography as a Primary Screening Tool for Refractive Surgery Candidates

G. C. Wong; J. Chang; M. D. Mifflin

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):580.

ARVO Annual Meeting Abstract May 2008

Experimental CNV After Transcleral Implantation of VEGF/bFGF-Implant Within the Suprachoroidal Space for Defining Potential Long-Term Synergistic Actions of Ranibizumab (Lucentis) With Small Low Cost Molecules in Ameliorating Wet AMD

C. G. Wong; T. C. Bruice; T. T. You

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1372.

ARVO Annual Meeting Abstract May 2008

Both Edema and Leakage Are Expressed and Are Separable in Long-Term Experimental CNV via Sustained Simultaneous Release of VEGF and bFGF Within the Suprachoroidal Space Through Transcleral Implantation of a Delivery Device

D. Rabin; T. C. Bruice; T. T. You; C. G. Wong

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1374.

ARVO Annual Meeting Abstract May 2008

Association of HTRA1 Polymorphism and Bilaterality in Advanced Age-Related Macular Degeneration

G. C. Wong; H. Chen; V. S. Hau; Z. Yang; D. Gibbs; X. Yang; P. Zhao; X. Ma; J. Zeng; K. Zhang

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):2661.

ARVO Annual Meeting Abstract May 2007

Comparison of Lucentis and Avastin in the Suprachoroidal VEGF/bFGF-Implant Rabbit CNV Model Provides a Potential Standardized Pre-Clinical Approach in the Rational Development of More Effective QSAR-Based Drugs, Sustained Release Formulations, & Drug Delivery Systems for Ameliorating AMD

C. G. Wong; T. Fedoruk; M. Bonakdar; T. T. You

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1786.

ARVO Annual Meeting Abstract May 2007

JSM6427, a Small Molecule Integrin Alpha5beta1 Inhibitor for Inhibition of Ocular Angiogenesis

G. Zahn; D. Vossmeyer; R. Stragies; M. Wills; C. G. Wong; J. Knolle

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):3430.

Advertisement